Biofilm III - candida Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

usual fungi presence on body

A

many

depending on immunosuppression and predisposition to disease impact their effect

inter-kingdom : candida doesnt exist in isolation - bacteria present as well

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

candida interactions with bacteria in oral cavity

A

Interact with many bacteria becomes different scenario especially in management, diagnosis and treatment

  • Periodontal disease
  • caries
  • angular cheilitis
  • denture related
  • endodontic PA infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

issue with swab and trying to demonstrate interkingdom interaction

A

Unclear in clinical swab – hard to differentiate in sample where organisms came from (i.e. site)

so hard to tell role in certain pathologies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

biovolume comparison

A

Yeast cells approx. 25-50x (likely 100) the biovolume of bacteria

  • Fungi occupy high physical volume in colonisation and infection

Provide physical scaffold for bacteria

  • ‘Mycofilms’
  • Create protective environment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

risk factors for developing candidiasis

A
  • Immuno-compromised pts
  • Immunosuppressive drugs
  • Advanced HIV infection
  • Intra-abdominal surgery
  • Central venous catheter
  • Parenteral nutrition
  • Broad-spectrum antibiotics
  • Dialysis
  • Colonisation at a sterile site
  • Diabetes
  • Burn unit pt
  • trauma pt
  • long-term corticosteroid use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

spectrum of canididal disease

A
  • Periodontitis
  • Dental implants
  • Denture stomatitis
  • CF lung infections
  • Ventilator associated pneumonia
  • Urinary tract infections
  • Infectious kidney stones/biliary tract infections
  • Chronic wounds
  • Musculoskeletal infections/osteomyelitis
  • Sutures
  • Endocarditis
  • Implant/medical device
  • Catheters and stents

Candidaemia is associated with considerable morbidity in critically ill patients leading to an overall prolonged ICU stay, a longer duration of mechanical ventilation and

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

classifications of oral candidosis (2 inital categories)

A

confined to mouth and commissure

generalised candidosis with oral manifestations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

confined to mouth and commisures

4

classes or oral candidosis

A

pseudomembranous

  • thrush

erythematous

  • atrophic (e.g. HIV related)
  • denture related

hyperplastic

  • candidal leukoplakia - premalignancy

angular cheilitis

  • causes great discomfort in elderly pts, stroke pt
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

example generalised candidosis with oral manifestations

A

chronic mucocutaneous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

pseudomembranous oral candidosis

A

thrush

  • white plaques pronounced on surface of mucosa
  • easily brushed away
    • may bleed

yeast and hyphe attached

more common pre retroviral therapy for HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

chronic hyperplastic oral candidosis

A

Hyphe Grow into tissue

  • cannot be scraped off

need to do a biopsy to ensure not pre-malignant lesion

long course of antifungal agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

angular cheilitis

A

Angles of mouth

  • Candida with interaction with gram +ve bacteria (staph)

Miconazole is key antifungal - topical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

miconazole

A

key antifungal for angular cheilitis

topical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

3 types of denture induced stomatitis (erythematous)

A

newton’s type I

  • localised inflammation

newton’s type II

  • diffuse inflammation

newton’s type III

  • granular inflammation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how does denture stomatitis develop

A

candida Adhere and colonise acrylic surfaces

  • Co-aggregation, biofilm formation, denture not cleaned effectively regularly
  • infiltrate into nooks and crannies of PMMA

pt may not be aware they have

Down to denture and oral hygiene need mechanical removal of organisms regularly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

5 signs and symptoms of denture stomatitis

A
  • Inflamed mucosa – particularly under upper denture
  • Burning sensation
  • Discomfort
  • Bad taste
  • In most cases patients are unaware of the problem
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

dangerous risk of denture stomatitis

A

remove denture at night

aspirate biofilm in sleep -> pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

candida species is

A

Opportunistic pathogenic yeasts

  • Candida albicans
  • Candida glabrata
  • Candida parapsilosis
  • Candida tropicalis

150 species of Candida described

  • Different sensitivities to antifungals used to treat pt

4th leading cause of nosocomial bloodstream infections

Morbidity and mortality rates unacceptably high:

  • Limited arsenal of antifungal drugs
  • Toxicity of some antifungal agents
  • Emergence of resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

candida albicans sensitive to

A

fluconazole and miconazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

candida glabrata sensitive to

A

no known used antifungals (e.g. fluconazole, miconazole)

more frequent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

why is there a limited arsenal of antifungal drugs that work

A

sensitvity variation of canidida species

  • Overuse of fluconazole and miconazole is driving epidemiological changes*
  • less albicans and more glabrata - issue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

candida albicans

site, presence

A
  • Present in 71% of healthy individuals
    • Oral carriage varies (35-55%)
  • Variable anatomical sites
    • Oral cavity, vagina, gut (mucosal surfaces)
  • Nutrient limitation/competition with bacteria
    • Issue with broad spectrum AB – candida able to outcompete bacteria  thrush
  • 35% mortality rate (ICU candida blood stream infection 50% mortality)
    • Various virulence attributes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

morphogensis of candida albicans

A

when stressed from hyphe

allow to move from adhering to tissue to invading the tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

difference between candida glabrata and albicans

A

candida albican - forms hype, sensitvie to antfungals

candida glabrata - doesn’t form hyphe but is intolerant to antifungals

differing pathogenicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

candidaemia

A

associated with considerable morbidity in critically ill patients leading to an overall prolonged ICU stay, a longer duration of mechanical ventilation and haemodialysis

candid adhere, make biofilm, invade into distal tissue causing severe systemic candidiasis infection

unlike pt will survive even when given antifungals and tx

26
Q

events leading denture stomatitis

A

candida in oral cavity/biofiilm

attach to denture surface (not removed by mechanical cleaning)

stressed - form hyphe and penetrate PMMA

form ECM

ECM thickens on denture surface - making it even more difficult to remove organisms

27
Q

hydrolytic enzymes

A

made within the biofilm by candida

an enzyme that catalyzes the hydrolysis of a substrate through the addition of water

28
Q

3 hydrolytic enzymes

A

phopholipase

haemolysin

proteinase

29
Q

phopholipase

substrate and contribution to infection

A

lipid

host cell penetration

30
Q

haemolysin

substrate and contribution to infection

A

red blood cells

facilitates hyphal invasion

31
Q

proteinase

substrate and contribution to infection

A

proteins

adhesion to epithelial cells

32
Q

uses of fungi

A

e.g. yeast

turns sugar (glucose) into alcohol and CO2

make beer and bread

33
Q

candida and oral cancer

A

Alcohol not carcinogenic

Acetaldehyde is a carcinogen

  • DNA damage
    • ADH enzymes in human and yeast
    • ADH genes key to biofilm formation

Can cause oral cancer processes

  • Chronic candida in mouth is imp driver in head and neck cancer
  • Autoimmune disease in bottlenecks of population – e.g. Finland*
  • Often get oral cancer in 20s
34
Q

how to diagnose pt with candidosis

A

Pseudomembranous

  • smear onto slide
    • hyphae? then candida albicans
      • treat with azole (biofilm intolerant but pt will respond to some extent)

Oral rinse - standard

Candida leukoplakia – biopsy

35
Q

phenotypic, biochemic and genotypic diagnosis of candida

A

chromgenic agar better than sabouraud agar

  • Different colours for colonies
  • Determine specific organisms
  • Often multiple mixed infections
  • Help determine tx
36
Q

antifungal therapy options (3)

A

azoles (FUNGISTATIC)

polyenes (FUNGICIDAL)

echinocandins

37
Q

fungi structure than impacts therapy

A

thick beta glucans

chitin is present which strengthens cell wall

38
Q

azoles

A

fungistatic

  • work indirectly on ergosterol
  • inhibiting molecules across the pathway prevent ergosterol being synthesised
39
Q

polyenes

A

fungicidal

  • better, can be very toxic
  • act directly on ergosterol
  • cause pores
    • leakage of cytomplasm contents = cell death and lysis
40
Q

echinocandins

A
  • Act on beta 1, 3 glucans synthase
    • Produce the beta glucans
  • Inhibit enzyme - Destabilise cell wall = cell death
  • Very good
    • Not currently used in dentistry yet
41
Q

5 antifungal drugs

A

nystatin amphotericin B

miconazole

fluconazole

itraconazole

chlorohexidine

42
Q

nystatin amphotericin B

preparations

activity

A

topical - suspension, pastilles, lozenges, ointment

all Candida sensitive

resistance rare and no antibac activity

pt compliance often poor

43
Q

miconazole

preparations

activity

A

topical - oral gel or cream

candida variable sensitivtiy

possess anti-staphylococcal activity

44
Q

fluconazole

preparations

activity

A

systemic - capsules

c albicans sensitive generally

c glabrata and krusei naturally resistant

45
Q

itraconazole

preparations

activity

A

systemic -capsules

systemic and topical - cyclodextrin solution

candida generall sensitive

little sign of resistance developing to date

46
Q

chlorohexidine

preparation

activity

A

topical - solution

antibacterial and anticandidal

47
Q

first line candida tx

A

Chlorhexidine useful antiseptic as antibacterial and anticandidal

  • Then move onto somehting else if pt doesn’t response

Flucanzole- can be pointless if glabrata or krusei

48
Q

azole resistance

A

work by inhibiting ergosterol indirectly

Changes across pathway or overexpression of certain elements

Leads to resistance and overexpression of CDR (candida drug resistance pumps) and MDR (multi drug resistance pumps)

  • Azoles spat straight out
49
Q

inappropriate tx of pts leads to

A
  • evolution and action - resistance to drugs (CDR and MDR pumps increase)*
  • Changes in genetics in organism as a result of how it is treated*
50
Q

antifungal penetrations of biofilm challenge

A

many things prevent

  • ECM
  • persisters
  • stress
  • density
  • efflux
  • over expressed targets
  • physiology
51
Q

pro and con of biofilm

A

help prevent fungal penetrations initially (biofilm resistance)

but then has features which prevent antifungal penetration

52
Q

dual resistance mechanisms

A

Staph aureus can coat is candida polymers

  • Becomes resistant to vacomycin

So in mix species biofilms have vancomyocin resistance (s.aureus use candida to protect themselves) and candida become miconazole resistant

use each other to evade drugs

53
Q

4 anti-fungal agents use in dentistry

A

Azoles ineffective against biofilms

  • need liposomal formulation to kill and penetrate through biofilm (as biofilm grows become intrinsic resistant to azole)

Polyenes and echinocandins active

Chlorhexidine effective

  • First go to

Novel antifungal compounds - Tea tree oil

54
Q

intrinsic resistance

A

innate ability of a bacterial species to resist activity of a particular antimicrobial agent through its inherent structural or functional characteristics, which allow tolerance of a particular drug or antimicrobial class.

55
Q

candida tx algorithm

A

think about pt and what is best for them in whole picture

56
Q

difference between candidosis and cadidiasis

A

no real difference

interchangeable

57
Q

is candidosis a problem

A

yes

managable but if left unchecked can become problematic - sore discomfort for pt

58
Q

what causes candidosis

A

Candida albicans and many more

  • Need to be able to differentiate them to know what treatment effective
59
Q

should we specifically diagnose and tx candidosis

A

Yes – disease of a disease

  • Underlying condition needs diagnosed and managed effectively
60
Q

how to dx and tx candidosis

A

Take an appropriate clinical specimen (swab, rinse, biopsy)

Treat with good OH, chlorohexidine then itraconazole, fluconazole then nystatin

  • If not responding then newer antifungals - echinocandins
61
Q

problems associated with dx and tx of candidosis (3)

A

Remember it is a biofilm – need to mechanical remove to be effective

More than one organism – deal with like that

If pt not responding to tx - reevaluate